/
Psychiatry
Post-Traumatic Stress Disorder
29
Pipeline Programs↗
117
Active Trials↗
35
Companies Involved↗
Post-Traumatic Stress Disorder is an emerging landscape with 29 programs across 35 companies. The most active players are Vanda Pharmaceuticals, Immedica Pharma AB, Transcend Therapeutics. 5 programs are in Phase 3.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical18
Phase 1
No programs
Phase 26
Phase 35
Approved
No programs
Analysis
Trial Status
292
clinical trials
Completed123 · 42%
Recruiting69 · 24%
Not yet recruiting27 · 9%
Unknown status18 · 6%
Terminated16 · 5%
Active, not recruiting15 · 5%
Other24 · 8%
Clinical Trials
Trial Activity
292 trials
Developing Innovative PTSD Treatment for Children: Reconsolidation of Traumatic Memories Protocol™ for Children (RTM-C Protocol)
Recruiting·—·Preclinical·NCT07185126·40 enrolled
Page 1 of 20
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)